TransMedics Group, Inc. (TMDX) EV/EBIT Ratio: 34.45x
Is TransMedics Group, Inc.’s EV/EBIT ratio high or low?
TransMedics Group, Inc.'s EV/EBIT ratio of 34.45x is 50% below its 2-year average of 68.54x, near the low end of its 2-year range (28.03x–112.68x).
As of Saturday, June 20, 2026. 36.19% below its 12-month average of 53.99x.
TMDX EV/EBIT Ratio Chart
TMDX Average EV/EBIT Ratio Chart
TMDX Current vs Average EV/EBIT Ratio Chart
TMDX EV/EBIT Ratio Metrics
EV/EBIT RATIO
34.45x
EV/EBIT RATIO AVG TTM
53.99x
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-36.19%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
TMDX Competitors' EV/EBIT Ratio
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TransMedics Group, Inc. (TMDX) | $2.72B | 34.45x | 53.99x | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.07B | 19.47x | 18.75x | 18.75x | 24.15x |
| 23andMe Holding Co. (ME)vs › | $15.31M | N/A | -0.28x | -1.89x | -7.82x |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.64B | 35.43x | 38.19x | 32.86x | 33.26x |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.91B | 288.34x | 101.56x | 148.57x | 148.57x |
| Tempus AI, Inc. (TEM)vs › | $8.87B | N/A | -27.13x | -28.45x | -29.28x |
| Charles River Laboratories International, Inc. (CRL)vs › | $8.91B | 25.15x | 62.10x | 38.56x | 35.07x |
| Baxter International Inc. (BAX)vs › | $10.27B | N/A | 442.63x | 243.35x | 134.31x |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | N/A | 25.59x | 34.39x | 25.01x |
| Revvity, Inc. (RVTY)vs › | $11.16B | 37.96x | 35.62x | 38.74x | 31.68x |
TransMedics Group, Inc. EV/EBIT Ratio Formula & Definition
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
TransMedics Group, Inc. EV/EBIT Ratio FAQ
- What is the EV/EBIT ratio for TransMedics Group, Inc. (TMDX)?
- The EV/EBIT ratio for TMDX stock is 34.45x.
- Is TransMedics Group, Inc.'s EV/EBIT ratio high or low?
- TransMedics Group, Inc.'s EV/EBIT ratio of 34.45x is 50% below its 2-year average of 68.54x, near the low end of its 2-year range (28.03x–112.68x).
- What is the TTM average EV/EBIT ratio for TransMedics Group, Inc. (TMDX)?
- The TTM average EV/EBIT ratio for TMDX stock is 53.99x.
TransMedics Group, Inc. EV/EBIT Ratio History
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-06-18 | 34.45x |
| 2026-06-17 | 32.32x |
| 2026-06-16 | 33.31x |
| 2026-06-15 | 33.18x |
| 2026-06-12 | 32.20x |
| 2026-06-11 | 32.46x |
| 2026-06-10 | 32.91x |
| 2026-06-09 | 32.73x |
| 2026-06-08 | 31.52x |
| 2026-06-05 | 30.86x |
| 2026-06-04 | 31.61x |
| 2026-06-03 | 30.96x |
| 2026-06-02 | 30.49x |
| 2026-06-01 | 30.13x |
| 2026-05-29 | 30.01x |
| 2026-05-28 | 30.25x |
| 2026-05-27 | 31.14x |
| 2026-05-26 | 31.26x |
| 2026-05-22 | 30.68x |
| 2026-05-21 | 30.64x |
| 2026-05-20 | 30.32x |
| 2026-05-19 | 29.60x |
| 2026-05-18 | 30.45x |
| 2026-05-15 | 28.48x |
| 2026-05-14 | 28.03x |
| 2026-05-13 | 28.85x |
| 2026-05-12 | 28.76x |
| 2026-05-11 | 28.90x |
| 2026-05-08 | 30.25x |
| 2026-05-07 | 32.19x |
| 2026-05-06 | 32.20x |
| 2026-05-05 | 40.64x |
| 2026-05-04 | 36.42x |
| 2026-05-01 | 37.52x |
| 2026-04-30 | 37.82x |
| 2026-04-29 | 36.98x |
| 2026-04-28 | 38.00x |
| 2026-04-27 | 40.58x |
| 2026-04-24 | 41.64x |
| 2026-04-23 | 42.50x |
| 2026-04-22 | 43.04x |
| 2026-04-21 | 40.88x |
| 2026-04-20 | 42.47x |
| 2026-04-17 | 43.50x |
| 2026-04-16 | 40.96x |
| 2026-04-15 | 43.59x |
| 2026-04-14 | 43.43x |
| 2026-04-13 | 42.56x |
| 2026-04-10 | 42.80x |
| 2026-04-09 | 40.99x |
| 2026-04-08 | 41.05x |
| 2026-04-07 | 40.28x |
| 2026-04-06 | 39.33x |
| 2026-04-02 | 37.78x |
| 2026-04-01 | 37.67x |
| 2026-03-31 | 37.30x |
| 2026-03-30 | 35.38x |
| 2026-03-27 | 37.16x |
| 2026-03-26 | 38.35x |
| 2026-03-25 | 39.45x |
| 2026-03-24 | 40.88x |
| 2026-03-23 | 42.07x |
| 2026-03-20 | 42.76x |
| 2026-03-19 | 42.69x |
| 2026-03-18 | 42.50x |
| 2026-03-17 | 46.84x |
| 2026-03-16 | 46.83x |
| 2026-03-13 | 46.37x |
| 2026-03-12 | 45.55x |
| 2026-03-11 | 48.44x |
| 2026-03-10 | 49.15x |
| 2026-03-09 | 50.63x |
| 2026-03-06 | 48.68x |
| 2026-03-05 | 52.62x |
| 2026-03-04 | 55.49x |
| 2026-03-03 | 55.61x |
| 2026-03-02 | 55.24x |
| 2026-02-27 | 54.58x |
| 2026-02-26 | 50.55x |
| 2026-02-25 | 49.53x |
| 2026-02-24 | 51.76x |
| 2026-02-23 | 57.73x |
| 2026-02-20 | 57.57x |
| 2026-02-19 | 56.98x |
| 2026-02-18 | 58.10x |
| 2026-02-17 | 57.38x |
| 2026-02-13 | 55.69x |
| 2026-02-12 | 55.13x |
| 2026-02-11 | 57.16x |
| 2026-02-10 | 59.71x |
| 2026-02-09 | 58.45x |
| 2026-02-06 | 57.91x |
| 2026-02-05 | 55.59x |
| 2026-02-04 | 55.92x |
| 2026-02-03 | 58.19x |
| 2026-02-02 | 57.45x |
| 2026-01-30 | 57.45x |
| 2026-01-29 | 59.57x |
| 2026-01-28 | 60.43x |
| 2026-01-27 | 59.37x |
| 2026-01-26 | 59.72x |
| 2026-01-23 | 58.01x |
| 2026-01-22 | 59.20x |
| 2026-01-21 | 57.38x |
| 2026-01-20 | 60.83x |
| 2026-01-16 | 61.44x |
| 2026-01-15 | 61.57x |
| 2026-01-14 | 60.84x |
| 2026-01-13 | 61.16x |
| 2026-01-12 | 57.74x |
| 2026-01-09 | 58.76x |
| 2026-01-08 | 58.97x |
| 2026-01-07 | 58.85x |
| 2026-01-06 | 56.89x |
| 2026-01-05 | 54.18x |
| 2026-01-02 | 52.66x |
| 2025-12-31 | 52.21x |
| 2025-12-30 | 52.33x |
| 2025-12-29 | 52.81x |
| 2025-12-26 | 53.30x |
| 2025-12-24 | 54.48x |
| 2025-12-23 | 55.00x |
| 2025-12-22 | 55.48x |
| 2025-12-19 | 54.77x |
| 2025-12-18 | 51.97x |
| 2025-12-17 | 52.33x |
| 2025-12-16 | 53.65x |
| 2025-12-15 | 52.85x |
| 2025-12-12 | 54.40x |
| 2025-12-11 | 54.75x |
| 2025-12-10 | 56.27x |
| 2025-12-09 | 57.80x |
| 2025-12-08 | 58.56x |
| 2025-12-05 | 58.52x |
| 2025-12-04 | 59.43x |
| 2025-12-03 | 60.05x |
| 2025-12-02 | 60.76x |
| 2025-12-01 | 64.43x |
| 2025-11-28 | 62.69x |
| 2025-11-26 | 62.45x |
| 2025-11-25 | 62.55x |
| 2025-11-24 | 60.10x |
| 2025-11-21 | 56.16x |
| 2025-11-20 | 53.14x |
| 2025-11-19 | 57.23x |
| 2025-11-18 | 50.27x |
| 2025-11-17 | 48.71x |
| 2025-11-14 | 49.39x |
| 2025-11-13 | 49.62x |
| 2025-11-12 | 51.17x |
| 2025-11-11 | 52.42x |
| 2025-11-10 | 52.53x |
| 2025-11-07 | 51.16x |
| 2025-11-06 | 53.63x |
| 2025-11-05 | 53.41x |
| 2025-11-04 | 52.45x |
| 2025-11-03 | 53.52x |
| 2025-10-31 | 56.41x |
| 2025-10-30 | 58.22x |
| 2025-10-29 | 57.59x |
| 2025-10-28 | 70.24x |
| 2025-10-27 | 71.70x |
| 2025-10-24 | 70.67x |
| 2025-10-23 | 69.82x |
| 2025-10-22 | 64.86x |
| 2025-10-21 | 65.17x |
| 2025-10-20 | 65.05x |
| 2025-10-17 | 63.85x |
| 2025-10-16 | 62.81x |
| 2025-10-15 | 61.19x |
| 2025-10-14 | 60.46x |
| 2025-10-13 | 60.71x |
| 2025-10-10 | 58.37x |
| 2025-10-09 | 61.38x |
| 2025-10-08 | 64.07x |
| 2025-10-07 | 62.55x |
| 2025-10-06 | 61.89x |
| 2025-10-03 | 62.82x |
| 2025-10-02 | 63.02x |
| 2025-10-01 | 62.40x |
| 2025-09-30 | 60.97x |
| 2025-09-29 | 61.20x |
| 2025-09-26 | 61.86x |
| 2025-09-25 | 61.87x |
| 2025-09-24 | 63.74x |
| 2025-09-23 | 65.38x |
| 2025-09-22 | 67.83x |
| 2025-09-19 | 66.31x |
| 2025-09-18 | 65.68x |
| 2025-09-17 | 65.00x |
| 2025-09-16 | 64.65x |
| 2025-09-15 | 62.08x |
| 2025-09-12 | 62.23x |
| 2025-09-11 | 63.51x |
| 2025-09-10 | 58.64x |
| 2025-09-09 | 58.89x |
| 2025-09-08 | 57.46x |
| 2025-09-05 | 56.63x |
| 2025-09-04 | 56.65x |
| 2025-09-03 | 58.18x |
| 2025-09-02 | 60.63x |
| 2025-08-29 | 62.43x |
| 2025-08-28 | 63.37x |
| 2025-08-27 | 63.71x |
| 2025-08-26 | 62.55x |
| 2025-08-25 | 62.44x |
| 2025-08-22 | 65.02x |
| 2025-08-21 | 64.47x |
| 2025-08-20 | 66.10x |
| 2025-08-19 | 66.52x |
| 2025-08-18 | 68.09x |
| 2025-08-15 | 69.10x |
| 2025-08-14 | 70.26x |
| 2025-08-13 | 71.48x |
| 2025-08-12 | 71.00x |
| 2025-08-11 | 68.95x |
| 2025-08-08 | 62.19x |
| 2025-08-07 | 63.01x |
| 2025-08-06 | 64.47x |
| 2025-08-05 | 68.14x |
| 2025-08-04 | 69.60x |
| 2025-08-01 | 65.39x |
| 2025-07-31 | 64.56x |
| 2025-07-30 | 58.59x |
| 2025-07-29 | 83.64x |
| 2025-07-28 | 83.95x |
| 2025-07-25 | 86.14x |
| 2025-07-24 | 85.13x |
| 2025-07-23 | 87.54x |
| 2025-07-22 | 84.22x |
| 2025-07-21 | 82.71x |
| 2025-07-18 | 87.48x |
| 2025-07-17 | 89.48x |
| 2025-07-16 | 90.09x |
| 2025-07-15 | 91.88x |
| 2025-07-14 | 92.80x |
| 2025-07-11 | 89.44x |
| 2025-07-10 | 98.80x |
| 2025-07-09 | 100.04x |
| 2025-07-08 | 98.76x |
| 2025-07-07 | 99.10x |
| 2025-07-03 | 102.15x |
| 2025-07-02 | 101.01x |
| 2025-07-01 | 102.84x |
| 2025-06-30 | 105.81x |
| 2025-06-27 | 103.87x |
| 2025-06-26 | 102.81x |
| 2025-06-25 | 101.69x |
| 2025-06-24 | 104.77x |
| 2025-06-23 | 100.89x |
| 2025-06-20 | 97.87x |
| 2025-06-18 | 98.21x |
| 2025-06-17 | 107.48x |
| 2025-06-16 | 111.86x |
| 2025-06-13 | 112.56x |
| 2025-06-12 | 112.68x |
| 2025-06-11 | 112.56x |
| 2025-06-10 | 111.02x |
| 2025-06-09 | 109.91x |
| 2025-06-06 | 109.64x |
Showing the most recent 260 of 410 data points. The chart above shows the full history.
Related Metrics
About TransMedics Group, Inc.
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung transplants; OCS Heart, designed for the extracorporeal perfusion and maintenance of donor hearts; and OCS Liver, dedicated to the preservation of donor livers. Founded in 1998, TransMedics is headquartered in Andover, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Waleed H. Hassanein